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ABSTRACT* 
Appropriate prescribing remains an important 
priority in all medical areas of practice.  
Objective: The objective of this study was to apply 
a Medication Appropriateness Index (MAI) to 
identify issues of inappropriate prescribing amongst 
patients admitted from the Emergency Department 
(ED). 
Method: This study was carried out at Malta’s 
general hospital on 125 patients following a two-
week pilot period on 10 patients. Patients aged 18 
years and over and on medication therapy were 
included. Medication treatment for 
inappropriateness was assessed by using the MAI. 
Under-prescribing was also screened for.  
Results: Treatment charts of 125 patients, including 
697 medications, were assessed using a MAI. 
Overall, 115 (92%) patients had one or more 
medications with one or more MAI criteria rated as 
inappropriate, giving a total of 384 (55.1%) 
medications prescribed inappropriately. The mean 
SD MAI score per drug was 1.78 (SD=2.19). The 
most common medication classes with 
appropriateness problems were biguanides (100%), 
anti-arrhythmics (100%) and anti-platelets (96.8%). 
The most common problems involved incorrect 
directions (26%) and incorrect dosages (18.5%). 
There were 36 omitted medications with untreated 
indications.  
Conclusion: There is considerable inappropriate 
prescribing which could have significant negative 
effects regarding patient care. 
 
Keywords: Inappropriate Prescribing. 
Pharmaceutical Services. Emergency Service, 
Hospital. Malta.  
 
                                            
*Lorna Marie WEST. MSc. Senior Clinical Pharmacist. 
Mater Dei Hospital. Tal-Qroqq (Malta). 
Maria CORDINA. PhD (QUB). Senior Lecturer. 
Department of Clinical Pharmacology and Therapeutics, 
University of Malta. Msida (Malta). 
Scott CUNNINGHAM. PhD. Head of Clinical Pharmacy 
and Pharmacy Practice. Robert Gordon University. 
Aberdeen (United Kingdom). 
EVALUACIÓN DEL FARMACÉUTICO 
CLÍNICO SOBRE LA INADECUACIÓN DE 
LA MEDICACIÓN EN UN SERVICIO DE 
URGENCIAS DE UN HOSPITAL 
UNIVERSITARIO EN MALTA 
 
RESUMEN 
La prescripción adecuada es una prioridad 
importante en todas las áreas de la práctica médica. 
Objetivo: El objetivo de este estudio fue aplicar el 
Medication Appropriateness Index (MAI) para 
identificar problemas de prescripción de 
medicación inadecuada entre los pacientes 
admitidos en un servicio de urgencias (ED). 
Método: Este estudio se realizó en el Hospital 
General de Malta sobre 125 pacientes después de 
un periodo piloto de dos semanas sobre 10 
pacientes. Se incluyeron pacientes de 18 o más 
años con medicación. La inadecuación del 
tratamiento se evaluó usando el MAI. También se 
evaluó la sub-prescripción. 
Resultados: Los perfiles de medicación de los 125 
pacientes, que incluían 697 medicamentos, se 
evaluaron con el MAI. En general, 115 pacientes 
(92%) tenían uno o más medicamentos con uno o 
más de los criterios del MAI evaluados como 
inadecuados, dando un total de 384 (55,1%) 
medicamentos prescritos inadecuadamente. La 
media (SD) de puntuación del MAI por 
medicamento fue de 1,78 (SD=2,19). Los grupos 
terapéuticos más comúnmente asociados a 
problemas de inadecuación eran las biguanidas 
(100%), anti-arritmicos (100%) y antiagregantes 
(96,8%). Los problemas más comunes incluían 
indicaciones incorrectas (26%) y dosis incorrectas 
(18,5%). Hubo 36 medicaciones omitidas con 
indicaciones no tratadas. 
Conclusión: Hay una considerable prescripción de 
medicación inadecuada que podría tener 
significativos efectos negativos en los cuidados del 
paciente.  
 
Palabras clave: Prescripción Inadecuada. Servicios 
Farmacéuticos. Servicio de Urgencia en Hospital. 
Malta. 
 
 
INTRODUCTION 
The pharmacist’s role has evolved over time, 
moving from traditional medication dispensing to 
involvement in direct patient care to the delivery of 
pharmaceutical care with a focus on enhancing 
medication appropriateness and preventing drug-
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related problems. Medication appropriateness 
combines different elements of evidence-based 
medicine with professional opinion when there is 
incomplete evidence.1 Clinical pharmacists optimise 
medication use and improve patient’s care when 
working as part of a multidisciplinary team in 
different settings, including hospital wards2,3, 
intensive care units4, and community-based 
physician group practices.5 A model for the 
provision of clinical pharmacy services has shown 
that understaffing of clinical pharmacists is likely in 
hospitals if all core clinical services were to be 
provided.6 Moreover, the literature is limited in 
reporting studies regarding models of practice that 
involve clinical pharmacists assigned exclusively to 
the emergency department (ED). 
The ED in general acute teaching hospitals is a 
busy environment where provision of optimal care is 
a challenge. It has been shown that in the ED 
patients are at risk of receiving suboptimal 
medication compared to that provided in inpatient 
and ambulatory care settings.7 Identifying and 
characterising inappropriate prescribing at the ED 
would show the need for clinical pharmacy services 
in this setting and could be the next step for 
developing a robust model of practice specifically 
for the ED. Therefore, the aim of this study was to 
apply the Medication Appropriateness Index (MAI)8 
by a clinical pharmacist to identify issues of 
inappropriate prescribing amongst patients admitted 
from the ED." 
 
METHODS  
The study was conducted over a two month period 
between November and December of 2005, in 
Malta at St Luke’s Hospital, a large acute general 
teaching hospital with 12,000 patient admissions 
per year. All patients aged 18 years and over, taking 
one or more medicines, who presented at the ED 
during the 2 month study period and who were 
forwarded to the care of any one of two participating 
consultant physicians were included in this study. 
The two month time frame was chosen as this was 
thought to be the reasonable time period which 
would provide a meaningful sample size. The study 
was approved by the Ethics Committee and 
confidentiality of the subjects was maintained. This 
study involved a cluster sample in a non-
randomized uncontrolled prospective study. A 
pragmatic convenience cluster sampling method of 
patients admitted under two specific consultants 
was chosen because the principal investigator was 
the clinical pharmacist attached to each of the 
admitting consultant physician teams. As such, this 
approach offered ‘real life’ characterisation of an 
existing model of practice. Patients who did not 
pass through the ED but were directly admitted to 
wards were excluded. These patients were not 
recruited because they would have been re-
assessed by other doctors apart from the ED 
physician and would have confounded the results.  
A total of 125 patients were recruited. Taking a level 
of confidence of 95% and an error of 10 (that is 
SD=5), the sample population was estimated to be 
that of 92 patients. The sample proportion, that is 
the number of patients having inappropriate 
prescriptions, to calculate the sample population 
was taken as 0.603. This sample proportion was 
estimated from previous studies which used the 
MAI.9,10 Inappropriate prescribing in these studies 
ranged from 46.1% to 74.5%. Therefore, a mean of 
60.3% (sample proportion) was used. An error of 10 
was used (±5) due to the fact that the difference in 
inappropriate prescribing in other studies was large. 
Therefore, to obtain a more accurate result 125 
patients were included in this study.  
Following medical assessment and intervention at 
ED, drug treatment charts and medical files 
containing case notes of study participants were 
reviewed by the principal investigator before the 
admitting consultant physician reviewed the 
patients. Treatment review of both acute and 
chronic medications a patient was on took place 
prior to the post-take ward round to ensure that any 
inappropriateness of medication detected did not 
arise due to an intervention by a doctor on the ward. 
Prescribing of acute medications and changes (or 
the lack of) in chronic drug treatment made by 
doctors at the ED were considered; as drug 
treatment after the patient was seen at the ED was 
reviewed for inappropriate prescribing. Each drug 
on the treatment chart was assessed to determine 
whether it is appropriate or not. Appropriateness of 
medication for each drug a patient was on was 
evaluated by using the MAI.8  
The MAI is designed to allow rating of ten explicit 
criteria to determine whether a given medication is 
appropriate for an individual. The ten criteria of the 
MAI, worded as questions, pertain to the individual 
patient and drug in question (Table 1). These 
criteria are: an indication for the drug, drug 
effectiveness for the patient’s condition, correct 
dosage and directions, practical directions, drug-
drug interaction, drug-disease interaction, 
unnecessary duplication with other drugs, duration 
of therapy and cost-effectiveness.8 Each criterion 
for the appropriateness of prescribing is rated on a 
three-point Likert scale, depending on whether the 
drug is appropriate, marginally appropriate or not 
Table 1. Medication Appropriateness Index8 
Question Score(a) 
1. Is there an indication for the drug? 3 
2. Is the medication effective for the condition? 3 
3. Is the dosage correct? 2 
4. Are the directions correct? 2 
5. Are the directions practical? 2 
6. Are there clinically significant drug-drug 
interactions? 2 
7. Are there clinically significant drug-
disease/condition interactions? 1 
8. Is there unnecessary duplication with other 
drug(s)? 1 
9. Is the duration of therapy acceptable? 1 
10. Is this drug the least expensive alternative 
compared with others of equal utility? 1 
Maximal score of inappropriateness 18 
aA weight of three is given for indication and effectiveness. A 
weight of two is assigned to dosage, correct directions, 
practical directions and drug-drug interactions. A weight of 
one is assigned to drug-disease interactions, expense, 
duplication and duration.9 These results in a total combined 
score of 0 to 18 (0 meaning the drug is appropriate and 18 
representing maximal inappropriateness). 
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appropriate. If additional information is required to 
answer a question “option Z”, which means “Do not 
know”, can be selected.  
If a drug is ‘Appropriate’ or ‘Marginally appropriate’ 
a score of zero is given to that drug. Each of the 10 
criteria of the MAI that is considered ‘Not 
appropriate’ is given a maximum score of 1, 2 or 3 
for each drug (Table 1). A weight of three is given 
for indication and effectiveness. A weight of two is 
assigned to dosage, correct directions, practical 
directions and drug-drug interactions. A weight of 
one is assigned to drug-disease interactions, 
expense, duplication and duration.9 This therefore 
results in a total combined score of 0 to 18 (0 
meaning the drug is appropriate and 18 
representing maximal inappropriateness). 
Combining the total MAI scores for each prescribed 
drug will yield a score for each patient. The total 
score per patient will depend on the number of 
drugs a patient is on. For example, if a patient is on 
one drug the minimum score would be 0 and the 
maximum score is 18; whilst if the patient is on 2 
drugs the minimum score per patient is 0 with a 
maximum score of inappropriateness of 36. 
To assess the reliability of the MAI intra-observer 
agreements were tested. The principal investigator 
used the MAI to collect data on 10 patients and then 
the MAI was re-used on the treatment chart of the 
same 10 patients by the principal investigator to 
collect the same data a month later. The tool 
resulted to be reliable since there was no difference 
in the data collected. Also, this ensured consistency 
in data collection by the principal investigator, who 
was the one who carried out the treatment chart 
review. A pilot study using the MAI was carried out 
by the principal investigator on 8% of the sample 
population being studied, i.e. 10 patients. The pilot 
study confirmed that no changes to the tool were 
required.  
The MAI does not detect omitted drugs, whereby a 
patient is suffering from a condition but he/she is not 
receiving drug treatment for it. For the purpose of 
the study, the number of documented conditions 
which were not treated according to international 
guidelines and for which there was no documented 
contra-indications for a medication were also 
recorded. These were divided into chronic 
conditions or acute conditions, depending whether 
they required long-term medication treatment or 
acute short courses of medications to be managed. 
All scores resulting from the MAI were inputted in 
the Statistical Packages of Social Sciences (SPSS) 
version 12 database which was constructed for data 
entry and analysis and this was password 
protected. This study used quantitative, including 
counts, percentages, mean (standard deviation), 
median and ranges, to yield frequencies. 
Cronbach’s Alpha, which is a measure of internal 
consistency, was used to assess reliability of the 
MAI. Cronbach's Alpha values vary from 0 to 1, with 
values closer to 1.0 indicating greater reliability. 
Values above 0.80 are preferable as indicators of 
internal consisteny of a tool, although values above 
0.70 are acceptable.11 Other studies assessing the 
use of the MAI used descriptive statistics as well, to 
analyse their data.9,10,12 
 
RESULTS  
Cronbach’s Alpha was higher than 0.889 for all 
criteria of the MAI, as illustrated in Table 2. The 
participant characteristics are presented in Table 3. 
The treatment charts of 125 patients were reviewed. 
Each patient was having one or more medicines 
and some of these medicines were prescribed in 
more than one patient. The 125 patients had a total 
of 697 drugs and each of these drugs were 
reviewed and assessed for appropriateness. Based 
on British National Formulary (BNF)13 drug 
categories, cardiovascular medications were the 
most commonly prescribed (Figure 1).  
A total of 313 drugs (44.9%) were considered to be 
appropriate out of which 56 drugs were marginally 
appropriate, whilst 55.1% (n=384) of drugs were 
prescribed inappropriately, i.e. 55.1% of drugs met 
one or more criteria of the MAI. Overall, 92% of the 
study population were prescribed one or more drugs 
inappropriately. Table 4 displays the total 
inappropriate prescriptions for each criterion of the 
MAI. The mean MAI score per drug was 1.78 
SD=2.19 and the mean MAI score per patient was 
9.90 SD=7.48 (Table 5). The score of inappropriate 
prescribing per patient in this study can range from 
0 to 234 since the maximum number of drugs 
encountered per patient was 13 and the maximum 
score for inappropriateness for each drug is 18. 
Biguanides (metformin), anti-arrhythmics 
(amiodarone), anti-platelets, antibiotics and steroids 
(inhaled and systemic) were the most 
inappropriately prescribed classes of drugs as they 
did not fulfil one or more of the MAI criteria, as 
Table 2. Cronbach’s Alpha for the ten criteria per MAI 
Question Cronbach’s 
Alpha 
1. Drug indication 1.000 
2. Effectiveness 1.000 
3. Correct dosage 1.000 
4. Correct directions 1.000 
5. Practical directions 1.000 
6. Drug-drug interaction 0.889 
7. Drug-disease/condition interactions 1.000 
8. Duplication 1.000 
9. Duration of therapy 0.978 
10. Expense 1.000 
Total score 1.000 
Table 3. Summary of patients’ characteristics 
Characteristic  
TOTAL 
 Men 
125 
71 (57%) 
Mean age in years (± SD) 
Age range 
67.46 SD=16.96 
19-95 
Total no of different medical 
conditions  
Range of medical conditions per 
patient 
35 
1-7 
Total number of drugs 
Mean no. of drugs per patient 
Median no. of drugs 
Range of drugs 
Medicines for chronic conditions 
Medicines for acute conditions 
697 
7.09 SD=2.74 
7 
1-13 
105 
17 
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indicated in Table 6. Directions were always omitted 
in metformin prescriptions and there were three 
instances when metformin was also prescribed in 
the wrong dose. Prescriptions for amiodarone were 
considered inappropriate due to inefficacy or 
incorrect dosages. Prescriptions for anti-platelets 
(aspirin and dipyridamole) were considered 
inappropriate mainly due to lack of directions. All of 
the prescriptions for antibiotics (except two) did not 
specify the duration of therapy and therefore were 
considered inappropriate. Apart from inappropriate 
duration, prescriptions for antibiotics were also 
considered as inappropriate since some of them did 
not fulfill one or more of the MAI criteria. Directions 
for administration of intravenuos hydrocortisone 
were omitted from all of the prescriptions.  
Thirty-six medical conditions, corresponding to 36 
omitted drugs, were encountered where a patient 
was suffering from a condition but was not receiving 
medications to manage the condition. These 36 
untreated indications were found in 32 patients 
(25.6% of the study population). The most common 
medications which were omitted in chronic medical 
conditions were an angiotensin-converting enzyme 
inhibitor in patients suffering from congestive heart 
failure (6 times), an anti-hypertensive medication in 
patients suffering from hypertension (4 times) and a 
beta-blocker in patients suffering from ischaemic 
heart disease (4 times). The only medication 
encountered which was omitted in an acute 
condition was paracetamol to manage patients with 
pyrexia (8 times). 
 
DISCUSSION 
The MAI was originally designed for older patients.9 
However, the MAI can be considered to be a 
reliable tool even in other age groups since results 
of the reliability studies did not show any statistical 
difference. Hanlon et al.12 used the MAI amongst 
elderly inpatients and physician-pharmacist pair's 
consensus rating for the 10 criteria of the MAI were 
used to measure inappropriate prescribing. Barber 
et al. 14 tried to establish whether judgements of 
appropriateness that included patients' perspectives 
and contextual factors could lead to different 
Table 4. Total inappropriate prescriptions for each criterion of the MAI 
Question Drugs with an inappropriate MAI criterion (n=697) 
Patients with an 
inappropriate prescription 
(n=125) 
 n % n % 
1. Drug indication 52 7.5 36 28.8 
2. Effectiveness 17 2.4 15 12.0 
3. Correct dosage 129 18.5 78 62.4 
4. Correct directions 181 26.0 91 72.8 
5. Practical directions 60 8.6 42 33.6 
6. Drug-drug interaction 37 5.3 28 22.4 
7. Drug-disease/condition interactions 23 3.3 19 15.2 
8. Duplication 16 2.3 15 12.0 
9. Duration of therapy 104 14.9 64 51.2 
10. Expense 77 11.0 52 41.6 
Figure 1: BNF
13
 Drug categories mostly prescribed (n = 697)
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conclusions when using instruments such as the 
MAI. The design differed from the current study as, 
apart from using the MAI, interviews were carried 
out with patients and doctors. Similar to the current 
study, Schmader et al. 15 employed a clinical 
pharmacist to assess prescribing appropriateness 
with the help of the MAI, however the study was 
carried out in an out-patient setting. No studies were 
identified which used the MAI in the ED. 
The results of this study show that 55.1% of the 
drugs prescribed during this study, based on MAI 
criteria8, were inappropriate for one reason or 
another. Inappropriate use of medication amongst 
patients is a common problem that often leads to 
increased risk of adverse drug events, healthcare 
utilisation, mortality and morbidity.16 In another 
study where the MAI was applied in an in-patient 
setting, the rate of inappropriate prescriptions was 
78.3%12, however the study design was different. 
Inappropriate prescriptions in primary healthcare 
studies ranged from 39.5%17 to 46.1%.10 Overall, 
92% of the study population had one or more 
medications with one or more of the MAI criteria 
rated as inappropriate. This finding is consistent 
with other studies that used the MAI where between 
91.9% to 94.3% of the patients were taking 
inappropriate drugs.10,12,17 Inadequate prescribing 
practice has been attributed to the difficulty 
prescribers had to understand clinical pharmacology 
and therapeutics.18 Such shortcomings may also be 
magnified by complex and poorly designed 
systems, poor teamwork and psychological and 
environmental stressors.19 This is of concern as 
inappropriate prescribing increases the likelihood of 
experiencing at least one adverse health outcome 
more than twofold20 and can also increase 
hospitalisations.21 
The major category of inappropriate prescribing 
encountered was incorrect or omitted directions for 
use, resulting in 26% of all prescriptions (Table 4). 
This occurred commonly with administration of 
drugs in relation to meals (example aspirin) and with 
the rate at which intravenous drugs should be 
administered. One may argue that ED doctors may 
give appropriate directions verbally to other health 
care professionals and patients. Whilst this is not 
incorrect, patients and ward staff should be given 
written instructions on the proper administration of 
drugs. This study also found that 8.6% of the 
prescriptions had impractical directions (Table 4). 
This is a low rate when compared to the study by 
Hanlon et al. which found impractical directions in 
up to 55.2% of prescriptions.12  
In this present study, incorrect dosages were the 
second most commonly encountered types of 
inappropriateness amongst prescriptions, with 
18.5% wrong dosages, when compared to those 
observed in other studies which varied between 
6.7%14 to 11.48% in the study by Hanlon et al.12 to 
17.3% reported by Schmader et al.22 Hanlon et al.12 
reported a lower number (50.9%) of patients with an 
inappropriate dosage when compared to the 
present study (62.4%). A retrospective study by 
Phillips et al. 23 concluded that incorrect dosing was 
the most common type of medication error resulting 
in patient death (40.9%).Prescriptions where no 
dosage was specified in this study were considered 
as inappropriate.  
Data from this study indicates that whilst 
inappropriate prescribing was encountered with 
55.1% of the drugs in this study, the extent of 
inappropriateness was a minimal one as the mean 
MAI score of inappropriate prescribing per drug was 
1.78 SD=2.19. Also, one could argue whether the 
ED is the right place for thorough medication 
review. Whilst serious drug related problems should 
be treated, it may be more convenient to 
recommend certain changes in drug therapy to the 
general practitioner or to the treating physician of 
the hospital ward after transfer from the ED. 
However, these results should not encourage 
complacency since inappropriate medication use 
does increase adverse health outcomes.20 
Moreover, studies have shown that pharmacists can 
significantly improve score of inappropriate 
prescribing.10,24  
The therapeutic classes involved in inappropriate 
prescribing differed from one study to another.12,20,22 
These observations may have important 
implications with regards to the need for improving 
prescribing practices by the implementation of 
protocols and hospital guidelines that could result in 
cost savings and less adverse effects. It is also 
pertinent to address the importance of an untreated 
indication even though this is not one of the MAI 
criteria. It is of concern that 25.6% of the study 
population did not receive a drug to manage their 
condition. Twenty-eight out of the 36 omitted drugs 
were to manage chronic conditions. Acute issues at 
hand can potentially mask some of the chronic 
issues that patients may also have. These findings 
suggest that doctors at the ED devote considerable 
time to the acute problem and prescribing for 
chronic diseases is overlooked, as confirmed by 
other studies.25 
The following limitations of the study need to be 
highlighted. The MAI was applied by one clinical 
pharmacist to detect inappropriate prescriptions. 
Secondly, while broadly applicable and easy to use, 
the MAI does not address some important 
medication use issues, including the causality of 
adverse drug reactions and patient adherence. In 
Table 5. MAI Score of inappropriate prescribing per drug 
and per patient 
Statistics Score per drug Score per patient 
Mean 1.78 SD= 2.19 9.90 SD=7.48 
Median 1.00 9.00 
Range 0-12 0-30 
Possible range 0-18 0-234 
Males 1.64 8.9 
Females 1.94 10.9 
Table 6. Most inappropriately prescribed classes of drugs  
Class of drug Total prescriptions 
Inappropriate 
prescriptions 
  n (%) 
Biguanides 12 12 (100.0) 
Anti-arrhythmics 10 10 (100.0) 
Anti-platelets 63 61 (96.8) 
Antibiotics 57 55 (96.5) 
Steroids 44 40 (90.9) 
Benzodiazepines 12 10 (83.3) 
Insulin 18 15 (83.3) 
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addition the MAI depends predominantly on 
pharmacological criteria, and so does not represent 
cases that would be considered appropriate when 
including the patient’s views and associated factors. 
Since the study was carried out over a two month 
period this does not account for seasonal variation. 
Also, the current study did not link the MAI scores 
with patient outcomes. Finally, since the principal 
investigator had limited the study to patients 
admitted under the care of two consultant 
physicians, these results cannot be extrapolated to 
other settings. However, they lend support to the 
use of the MAI as an aid to the clinical pharmacists 
in identifying medication inappropriateness in the 
ED setting. 
 
CONCLUSIONS 
Suboptimal care is present as evidenced by the vast 
range of inappropriate prescribing encountered in 
this study. The data presented herein reiterate the 
importance of a clinical pharmacist practising at the 
ED. The inclusion of pharmacists as part of a 
multidisciplinary team can assist in appropriate 
prescribing, as well as in the implementation of 
standard operating procedures and evidence-based 
guidelines to be used in the ED, amongst other 
tasks. Notwithstanding the limitations, the MAI can 
aid clinical pharmacists identify medication 
inappropriateness even in the ED setting. 
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